Content area
Abstract
Purpose
Genomic studies have demonstrated the necessity of ethnicity-specific population data to ascertain variant pathogenicity for disease diagnosis and treatment. This study examined the carrier prevalence of treatable inherited disorders (TIDs), where early diagnosis of at-risk offspring can significantly improve clinical outcomes.
Methods
Existing exome/ genome sequencing data of 831 Singaporeans were aggregated and examined for disease causing variants in 104 genes associated with 80 TIDs.
Results
Among the 831 Singaporean participants, genomic variant filtering and analysis identified 1 in 18 individuals (6%) to be carriers amongst one of 13 TIDs. Citrin deficiency and Wilson disease had the highest carrier frequency of 1 in 41, and 1 in 103 individuals, respectively. The pathogenic variants associated with citrin deficiency were 24 times more prevalent in our local cohorts when compared to Western cohorts.
Conclusion
This study demonstrates the value of a population specific genomic database to determine true disease prevalence and has enabled the discovery of carrier frequencies of treatable genetic conditions specific to South East Asian populations, which are currently underestimated in existing data sources. This study framework can be adapted to other population groups and expanded to multiple genetic conditions to inform health policies directing precision medicine.
Details
1 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University Hospital, Inherited Cardiac Clinic, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599)
2 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); KK Women’s and Children’s Hospital, Department of Paediatrics, Singapore, Singapore (GRID:grid.414963.d) (ISNI:0000 0000 8958 3388)
3 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Duke-NUS Medical School, Cancer and Stem Biology, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
4 National Heart Centre Singapore, Department of Cardiology, Singapore, Singapore (GRID:grid.419385.2) (ISNI:0000 0004 0620 9905)
5 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
6 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Duke-NUS Medical School, Cardiovascular and Metabolic Disorders, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
7 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Duke-NUS Medical School, Cancer and Stem Biology, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); National Cancer Centre, Division of Medical Sciences, Singapore, Singapore (GRID:grid.410724.4) (ISNI:0000 0004 0620 9745)
8 KK Women’s and Children’s Hospital, Department of Paediatrics, Singapore, Singapore (GRID:grid.414963.d) (ISNI:0000 0000 8958 3388)
9 KK Women’s and Children’s Hospital, Department of Paediatrics, Singapore, Singapore (GRID:grid.414963.d) (ISNI:0000 0000 8958 3388); Duke-NUS Medical School, Paediatrics ACP, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
10 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Duke-NUS Medical School, Cancer and Stem Biology, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); Technology and Research, Biomedical Research Council, Agency for Science, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221)
11 National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Eye ACP, Duke-NUS Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
12 Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Eye ACP, Duke-NUS Medical School, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
13 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National Heart Centre Singapore, Department of Cardiology, Singapore, Singapore (GRID:grid.419385.2) (ISNI:0000 0004 0620 9905); Duke-NUS Medical School, Cardiovascular and Metabolic Disorders, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
14 National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Technology and Research, Genome Institute of Singapore, Agency for Science, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221)
15 SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); KK Women’s and Children’s Hospital, Department of Paediatrics, Singapore, Singapore (GRID:grid.414963.d) (ISNI:0000 0000 8958 3388); Duke-NUS Medical School, Paediatrics ACP, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)